Major Bleeding*
Event rate (%/year)
Apixaban
Enoxaparin/Warfarin
0.6
1.8
0.6
n = 15
1.8
n = 49
N = 2676
N = 2689
69% RRR, 1.2% ARR,

RR, 0.31 (95% CI, 0.17-0.55), P <.0001

 
Components of Major Bleeding
Bleeding outcome Apixaban Enoxaparin/Warfarin
  Patients
w/Event
(no.)
Event
rate
(%/y)
Patients
w/Event
(no.)
Event
rate
(%/y)
Fatal
bleeding
1 <0.1 2 0.1
Nonfatal major
bleeding at a
critical site
4 0.1 14 0.5
Other nonfatal
major bleeding
10 0.4 33 1.2